BioSmart Rises 7.45% Amid COVID-19 (Diagnostic Kit) Theme Uptrend

On the 6th, the COVID-19 (diagnostic kit) theme showed strength by rising 3.25% compared to the previous day, while Biosmart, a related stock drawing attention, surged 7.45% compared to the previous day. Biosmart is known as a credit card manufacturer as well as a cosmetics manufacturing and distribution company.

[Graph] Major stock price changes in the COVID-19 (diagnostic kit) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Biosmart exceeded the theme's average scores in growth, stability, and profitability, ranking 3rd in the quant financial ranking (out of 32 stocks). This can be interpreted as Biosmart having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.